KEY DETAILS
Arbor locks GLP-1 prices for life and offers a 12-month money-back guarantee.
Arbor's compounded semaglutide plans start at $99 a month and compounded tirzepatide at $149.
Kentucky's 1990s Medicaid rules keep the state out of CMS's BALANCE Model, which would let Medicaid cover GLP-1s for about $70 a dose.
Stopping a GLP-1 medication may lead to regaining lost weight, according to an expert.
As we reported on September 13, Megan Winstanley says she lost eight stone without Mounjaro or Wegovy.
Arbor, a telehealth platform for compounded GLP-1 medications, is promoting an offer to lock prices for life and back new patients with a 12-month money-back guarantee. The move lands the same week Kentucky Medicaid rules are shown to be keeping the state out of a federal Medicaid program that could cut GLP-1 costs for residents there, and a reminder from a weight-loss expert that stopping these drugs can undo the progress they helped create. We also return to a story from September 13, a woman who lost eight stone without Mounjaro or Wegovy.
The lifetime price lock is the central feature of Arbor's offer. Arbor is telling patients that whatever rate they lock in when they start treatment stays fixed for as long as they remain on the plan, through its telehealth platform for compounded GLP-1 medications. The 12-month money-back guarantee adds a second layer of protection, giving new patients a full year to decide whether the medication is working for them before they are locked into a plan they regret. For patients comparing options, that combination of a guaranteed price and a refund window may be worth weighing against other telehealth providers.
Plans start at $99 per month for compounded semaglutide and $149 per month for compounded tirzepatide, according to a USA Today shopping guide. Patients connect with licensed providers online who review their eligibility before prescribing either medication, a process similar to other telehealth weight-loss platforms already on the market. The final monthly cost will still depend on the specific plan and dose a provider recommends, so the starting rates should be treated as a floor rather than a guaranteed price for every patient. Anyone considering the offer should confirm exactly what is included in that starting rate before committing to a full year of treatment.
Cost is also the sticking point in Kentucky. CMS's BALANCE Model would let state Medicaid programs cover GLP-1s for about $70 a dose, and states can apply through January 2027. But Kentucky regulations written during the 1990s weight-loss drug craze keep the state from joining, and the Kentucky Medical Association is pushing to change them. The gap points to a familiar pattern, where federal programs move to expand access but state-level rules take time to catch up. Joining would take action from both the state legislature and the governor's office.
Price is one part of the GLP-1 decision, and what happens after treatment is another. A patient recently asked an expert a direct question: if they stop taking the medication, will they lose the progress they made? The expert's answer was straightforward. Stopping a GLP-1 medication can lead to regaining the weight that was lost while on it, because the drug's effect on appetite and metabolism does not necessarily carry over once treatment ends. That answer is worth weighing alongside any pricing offer, since a lower monthly cost still means committing to treatment for the long term if the goal is to keep the weight off.
Not every weight-loss result comes from a GLP-1 medication, though. As we reported on September 13, Megan Winstanley told the Mirror she lost eight stone and reached the best shape of her life through diet changes, swimming and bodybuilding, without Mounjaro or Wegovy. Her story stands as a reminder that these medications are one path among several, not the only route to significant weight loss. For readers weighing whether a GLP-1 plan is worth the cost, it may help to remember that non-drug approaches remain part of the picture too.
For readers shopping for compounded GLP-1 plans, the practical takeaway is to read the terms behind any lifetime price lock or money-back guarantee before signing up, and to ask what the monthly rate will actually cover as doses change. It also helps to think past the first year of treatment, considering what happens if you stop and whether you have a plan for maintaining results either way. If you're on Kentucky Medicaid and hoping the BALANCE Model will lower your GLP-1 costs, it is worth asking your state legislators whether they plan to change the rules. Whatever path you choose, the medication is a tool, not the only route to reaching your goal.
Originally published on GLP-1 Nation.
Every Sunday, the weekly newsletter pulls the full week together: the news from GLP-1 Nation, the access updates from GLP1Laws, the latest GLP-1 Studio podcast episodes, and what changed in the Cozy Butter community.